Markets

Insider Trading

Hedge Funds

Retirement

Opinion

10 Best Beaten Down Growth Stocks to Buy According to Analysts

In this article, we will look at the 10 Best Beaten Down Growth Stocks to Buy According to Analysts.

​On October 27, Tejas Dessai, Director of Research at Global X ETFs, joined CNBC Television for an interview to discuss how the big tech earnings this week are expected to impact the broader stock market. He noted that the current week is crucial for the market, as it is expected to set the tone for the AI trade heading into the end of the year. He noted that earnings overall have been strong for the quarter and highlighted that investors will be closely watching the earnings set to be released this week. Dessai highlighted that investors are more focused on capital expenditure guidance by hyperscalers and AI revenue surprises. He noted that these two factors are particularly important because an increase in expenditure indicates that companies have confidence in AI, and revenue surprises provide justification for the huge amount of money being allocated.

​Dessai believes that it is this capital expenditure and monetization of AI that is expected to drive markets higher into 2026. Dessai expects that the hyperscaler capital expenditure will reach $350 billion in 2025 and $490 billion in 2026. While answering a question regarding the alternative case scenario, where the capital expenditure fails to meet market expectations. Dessai notes that this is only possible if the big tech companies do not see the AI potential and innovation delivering as per the expectations. However, he adds that this is unlikely at the moment as the demand for AI continues to outweigh supply in almost a 10-to-1 ratio. Therefore, Dessai expects the tech companies to continue increasing the capital expenditure and, at the same time, deliver on revenue growth estimates as well.

​With that, let’s take a look at the 10 Best Beaten Down Growth Stocks to Buy According to Analysts.

Our Methodology

To curate the list of 10 Best Beaten Down Growth Stocks to Buy According to Analysts, we used the Finviz Stock Screener, CNN, Yahoo Finance, Seeking Alpha and Insider Monkey’s Q2 hedge fund database as our sources. Using the screener, we aggregate a list of growth stocks trading within 0% to 10% of their 52-week lows, with FWD EPS Growth of at least 15%, and analysts expect more than 25% upside. Next, we cross-checked the stock price and 52-week range from Yahoo Finance, FWD EPS Growth from Seeking Alpha, and analyst upside potential from CNN. Lastly, we ranked the stocks in ascending order of the upside potential. We have also added the hedge fund sentiment around each stock sourced from Insider Monkey’s database. Please note that the data was recorded on October 30.

​​​Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 427.7% since May 2014, beating its benchmark by 264 percentage points (see more details here).

​10 Best Beaten Down Growth Stocks to Buy According to Analysts

10. T-Mobile US, Inc. (NASDAQ:TMUS)

Price: $215.01

52-Week Range: 208.39 – 276.49

FWD EPS Growth: 19.50%

Number of Hedge Fund Holders: 76

Analyst Upside Potential: 27.90%

T-Mobile US, Inc. (NASDAQ:TMUS) is one of the Best Beaten Down Growth Stocks to Buy According to Analysts. Wall Street has a mixed opinion on T-Mobile US, Inc. (NASDAQ:TMUS) since it released its fiscal third quarter results on October 23. The company topped EPS estimates for the quarter by $0.20; however, the revenue of $21.96 billion fell short of the consensus by $7.29 million.

Recently, on October 28, Laurent Yoon from Bernstein reiterated a Hold rating on T-Mobile US, Inc. (NASDAQ:TMUS) with a price target of $265.

Earlier on October 23, Michael Funk of Bank of America Securities had also reiterated a Hold rating on the stock with a price target of $270. Funk noted that the company posted strong results during the third quarter. He highlighted subscriber growth, postpaid phone net additions, and service revenue as key indicators where T-Mobile US, Inc. (NASDAQ:TMUS) exceeded expectations.

Additionally, the company updated its guidance, suggesting management’s confidence in the company’s growth potential. However, Funk maintained a Hold rating despite these strong results because he believes the company’s current market valuation already incorporates these performance metrics, thereby reducing further upside.

T-Mobile US, Inc. (NASDAQ:TMUS) provides wireless communication services across the United States, Puerto Rico, and the Virgin Islands under brands including T-Mobile, Metro by T-Mobile, and Mint Mobile.

9. ​NICE Ltd. (NASDAQ:NICE)

Price: $134.31

52-Week Range: 126.66 – 200.65

FWD EPS Growth: 15.69%

Number of Hedge Fund Holders: 23

Analyst Upside Potential: 41.46%

​NICE Ltd. (NASDAQ:NICE) is one of the Best Beaten Down Growth Stocks to Buy According to Analysts. On October 21, Morgan Stanley assumed coverage of NICE Ltd. (NASDAQ:NICE) with an Overweight rating and a $193 price target.

​The firm noted that the Q3 checks for the software segment were generally stable. However, it was moderate considering the performance from Q1 to Q2. Morgan Stanley notes that while expectations for the software segment are low, any potential upside is unlikely to change investor sentiment.

​In addition to Morgan Stanley, on October 12, Samad Samana from Jefferies also initiated coverage of NICE Ltd. (NASDAQ:NICE) with a Hold rating and a price target of $152.

The company is set to release its FQ3 results on November 13. Management during the second quarter earnings release noted they expect third quarter non-GAAP revenue in the range of $722 million to $732 million, indicating 5% year-over-year growth at the midpoint. In addition, the non-GAAP diluted EPS is anticipated in the range of $3.12 to $3.22, reflecting 10% year-over-year growth.

​NICE Ltd. (NASDAQ:NICE) is an international enterprise software provider that provides software that helps businesses improve customer interactions and prevent financial crimes.

8. Shift4 Payments, Inc. (NYSE:FOUR)

Price: $70.01

52-Week Range: 68.09 – 127.50

FWD EPS Growth: 34.58%

Number of Hedge Fund Holders: 55

Analyst Upside Potential: 42.84%

​Shift4 Payments, Inc. (NYSE:FOUR) is one of the Best Beaten Down Growth Stocks to Buy According to Analysts. On October 29, Peter Heckmann from D.A. Davidson lowered the firm’s price target on ​Shift4 Payments, Inc. (NYSE:FOUR) from $124 to $114, while keeping a Buy rating on the stock.

Heckmann lowered the price target for the company as it approaches its fiscal third-quarter earnings, scheduled to be announced on November 6, 2025. As per the company’s guidance, it expects gross revenue less network fees for the third quarter to be around $590 million and adjusted EBITDA of approximately $290 million.

For the full year, management maintained its volume range of $200 billion to $220 billion and expects gross revenue less network fees in the range of $1.965 billion to $2.035 billion. The analyst expects the company to meet or modestly exceed the forecasts. Heckmann also expects the management to affirm or increase the full-year guidance. The analyst also noted in his research note that investors expect ​Shift4 Payments, Inc. (NYSE:FOUR) to slow the pace of additional acquisitions till mid-2026 and should focus on integrating recent deals.

​Shift4 Payments, Inc. (NYSE:FOUR) provides software and payment processing solutions across the United States, supporting various payment methods like credit cards, mobile wallets, and alternative payment options.

7. Tyler Technologies, Inc. (NYSE:TYL)

Price: $478.00

52-Week Range: 475.77 – 661.31

FWD EPS Growth: 17.30%

Number of Hedge Fund Holders: 46

Analyst Upside Potential: 43.31%

​Tyler Technologies, Inc. (NYSE:TYL) is one of the Best Beaten Down Growth Stocks to Buy According to Analysts. On October 30, Jonathan Ho from William Blair maintained a Buy rating on ​Tyler Technologies, Inc. (NYSE:TYL) without disclosing any price targets. The rating follows the company’s fiscal third-quarter results released on October 29.

​Tyler Technologies, Inc. (NYSE:TYL) topped EPS and revenue estimates by $0.11 and $1.53 million, respectively. Analyst Ho highlighted the company’s solid financial performance, driven by a substantial increase in subscription and SaaS revenue.

Ho also likes management’s optimistic full-year guidance of revenues in the range of $2.335 billion to $2.360 billion and GAAP diluted EPS in the range of $7.28 to $7.48. He highlighted that Tyler Technologies, Inc. (NYSE:TYL) is focused on cloud adoption and AI initiatives. This, topped with its revenue mix, enables the company to offer a predictable revenue model and improved margins.

​Tyler Technologies, Inc. (NYSE:TYL) provides integrated software and technology solutions tailored for the public sector.

6. ​Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

Price: $29.32

52-Week Range: 25.52 – 40.93

FWD EPS Growth: 23.25%

Number of Hedge Fund Holders: 27

Analyst Upside Potential: 46.66%

​Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is one of the Best Beaten Down Growth Stocks to Buy According to Analysts. On October 24, Danielle Brill from Truist Financial reiterated a Buy rating on Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) without disclosing any price targets.

The rating follows the company’s pre-announcement of strong Q3 2025 WAKIX performance on October 23. The franchise generated around $239 million in revenue during the third quarter, reflecting 29% year-over-year growth. Management noted that these results were driven by a record rise in the average number of patients. The number of patients increased by 500 during the quarter to reach 8,100 average patients.

​In addition, Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) also increased its revenue guidance for 2025 to a range of $845 million – $865 million versus the previous range of $820 million – $860 million.

​Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) develops and commercializes therapies for rare neurological diseases and other unmet medical needs.

5. Vertex, Inc. (NASDAQ:VERX)

Price: $23.24

52-Week Range: 23.05 – 60.71

FWD EPS Growth: 25.17%

Number of Hedge Fund Holders: 25

Analyst Upside Potential: 48.45%

Vertex, Inc. (NASDAQ:VERX) is one of the Best Beaten Down Growth Stocks to Buy According to Analysts. Wall Street has a mixed opinion on Vertex, Inc. (NASDAQ:VERX) as the company approaches its fiscal third-quarter results, scheduled to be announced on November 3. Management expects the quarterly revenue to be in the range of $190 million to $193 million. While the adjusted EBITDA is anticipated to reach $39% million at the mid-point.

On October 28, Steve Enders from Citi maintained a Hold rating on Vertex, Inc. (NASDAQ:VERX) and lowered the price target from $31 to $29.

However, earlier on October 21, Joshua Reilly from Needham reiterated a Buy rating on the stock with a price target of $40. The analyst sees the appointment of Mr Young as the CEO of the company to be a positive step. He noted that Young’s experience in top technology companies is anticipated to bring operational efficiency to Vertex, Inc. (NASDAQ:VERX). Reilly also highlighted the company’s pre-release of fiscal third-quarter earnings, which showed a significant EBITDA beat and a modest revenue beat.

Vertex, Inc. (NASDAQ:VERX) provides global software solutions for indirect tax calculation, compliance, and analytics through licenses and cloud subscriptions.

4. Duolingo, Inc. (NASDAQ:DUOL)

Price: $272.76

52-Week Range: 256.63 – 544.93

FWD EPS Growth: 138.51%

Number of Hedge Fund Holders: 55

Analyst Upside Potential: 55.81%

Duolingo, Inc. (NASDAQ:DUOL) is one of the Best Beaten Down Growth Stocks to Buy According to Analysts. The company is set to release its fiscal third quarter results on November 5, 2025. Wall Street has a mixed opinion on the stock before the release.

On October 28, Nat Schindler from Scotiabank reiterated a Buy rating on Duolingo, Inc. (NASDAQ:DUOL) with a $600 price target. However, earlier on October 23, Curtis Nagle from Bank of America Securities lowered the firm’s price target from $450 to $370, while reiterating a Hold rating on the stock.

The analyst noted that they forecast third-quarter revenue for the company to be around $261.5 million, which is slightly above the Street estimates. Whereas the EBITDA estimates by BofA of $72 million are in in-line with the consensus. The analyst highlighted that  Duolingo, Inc. (NASDAQ:DUOL) has demonstrated strong growth and has grown its revenue by nearly 40% over the trailing twelve months.

In addition, the firm anticipates the company to deliver daily active users growth of 35% and monthly active user growth of 18%. For the full year, the bank estimates the company to deliver $1.02 billion in revenue and $295 million in EBITDA.

Duolingo, Inc. (NASDAQ:DUOL) offers a mobile and web-based language learning platform with courses in over 40 languages, operating on a freemium model with premium subscription options.

3. Klaviyo, Inc. (NYSE:KVYO)

Price: $25.39

52-Week Range: 23.44 – 49.55

FWD EPS Growth: 26.57%

Number of Hedge Fund Holders: 41

Analyst Upside Potential: 77.24%

Klaviyo, Inc. (NYSE:KVYO) is one of the Best Beaten Down Growth Stocks to Buy According to Analysts. Wall Street is bullish on Klaviyo, Inc. (NYSE:KVYO) ahead of its fiscal third-quarter results. The company is expected to release earnings on November 5, 2025.

On October 21, Samad Samana from Jefferies initiated Klaviyo, Inc. (NYSE:KVYO) with a Buy rating and a $32 price target. The stock price has decreased 38.76% on a year-to-date basis, Samana noted in his research note that which was mainly due to AI concerns. Regardless, the firm believes that the risk is priced in the current valuation. Moreover, the firm also sees the company’s risk/reward skewed positively.

Earlier on October 1, Rayan MacWilliams from Wells Fargo also initiated coverage of the stock with a Buy rating and a price target of $40. Similar to Jefferies, Wells Fargo also has a positive outlook on Klaviyo, Inc. (NYSE:KVYO). The analyst explained in his research note that this is driven by the company’s unique position to embed AI, along with the ability to generate strong margins and free cash flow.

Management raised full-year guidance during the second quarter of 2025. It now expects revenue to be between $1.195 billion and $1.203 billion, reflecting 27% to 28% year-over-year growth.

Klaviyo, Inc. (NYSE:KVYO) provides customer relationship management platforms to businesses. Its platform is specifically designed for Business-to-Consumer brands, focusing on unifying marketing analytics and customer service into one integrated solution.

2. ​BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

Price: $51.86

52-Week Range: 51.57 – 73.51

FWD EPS Growth: 37.26%

Number of Hedge Fund Holders: 58

Analyst Upside Potential: 82.22%

​BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the Best Beaten Down Growth Stocks to Buy According to Analysts. On October 19, Sean Laaman from Morgan Stanley maintained a Buy rating on BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) with a price target of $104.

​The analyst likes the company’s market position and growth potential. He noted that the company’s international expansion of Voxzogo has shown revenue growth. He expects the management to continue expanding Voxzogo in other countries and noted it to be one of the key drivers for the company.

​Laaman also noted the promising pipeline of the company. He highlighted BMN 351 and BMN 333 as potential catalysts for future growth. He noted that a strong pipeline topped by BioMarin Pharmaceutical Inc. ‘s (NASDAQ:BMRN) ability to maintain its leadership in skeletal dysplasias despite the challenges further strengthens its position in the market.

​BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is an international biopharmaceutical company that develops and commercializes targeted therapies addressing the root causes of rare genetic conditions.

1. ​Fiserv, Inc. (NYSE:FI)

Price: $70.60

52-Week Range: 66.58 – 238.59

FWD EPS Growth: 16.15%

Number of Hedge Fund Holders: 94

Analyst Upside Potential: 140.79%

​Fiserv, Inc. (NYSE:FI) is one of the Best Beaten Down Growth Stocks to Buy According to Analysts. On October 30, Stephen Biggar from Argus Research reiterated a Hold rating on ​Fiserv, Inc. (NYSE:FI) without disclosing any price target.

The analyst noted that the company has lowered the EPS guidance for 2025 significantly. Moreover, he also noted that the company needs to reset its margin and growth targets after its decision to defer investments in the business. Biggar believes that the company needs to rebuild confidence in the company’s growth prospects to ensure that the stock price recovers.

Earlier on October 24, Andrew Harte from BTIG reiterated a Buy rating on Fiserv, Inc. (NYSE:FI) with a price target of $180.

​Moreover, on October 22, Andrew Bauch from Wells Fargo also initiated a Hold rating on the stock with a price target of $130. The analyst noted that started coverage on 20 stocks in the payments and processors, and IT services industry.

Bauch believes that the payments sector has suffered due to the rotation to AI-centric stocks, along with below-average execution from many companies. However, he still remains optimistic about the payments sector and noted that too many companies in the space have been painted with the same brush.

​Fiserv, Inc. (NYSE:FI) is a leading fintech company that provides a range of solutions to help businesses process and manage payments and transactions. The company operates through two main business segments, namely Merchant Solutions and Financial Solutions.

While we acknowledge the potential of FI to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than FI and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.